Any 0 3 0 3 O
known 4 9 4 9 O
allergy 10 17 10 17 O
to 18 20 18 20 O
any 21 24 21 24 B-allergy_name
component 25 34 25 34 I-allergy_name
of 35 37 35 37 I-allergy_name
the 38 41 38 41 I-allergy_name
delivery 42 50 42 50 I-allergy_name
vehicle 51 58 51 58 I-allergy_name

Any 0 3 59 62 O
ocular 4 10 63 69 B-treatment
surgery 11 18 70 77 I-treatment
including 19 28 78 87 O
laser 29 34 88 93 B-treatment

Any 0 3 94 97 O
pre 4 7 98 101 O
- 7 8 101 102 O
existing 8 16 102 110 O
factor 17 23 111 117 O
or 24 26 118 120 O
past 27 31 121 125 O
history 32 39 126 133 O
of 40 42 134 136 O
eye 43 46 137 140 B-chronic_disease
disease 47 54 141 148 I-chronic_disease
in 55 57 149 151 O
children 58 66 152 160 O
that 67 71 161 165 O
may 72 75 166 169 O
predispose 76 86 170 180 O
to 87 89 181 183 O
an 90 92 184 186 O
increased 93 102 187 196 O
risk 103 107 197 201 O
of 108 110 202 204 O
surgical 111 119 205 213 O
complications 120 133 214 227 O
in 134 136 228 230 O
the 137 140 231 234 O
study 141 146 235 240 O
eye 147 150 241 244 O
( 151 152 245 246 O
eg 152 154 246 248 O
, 154 155 248 249 O
trauma 156 162 250 256 B-chronic_disease
, 162 163 256 257 O
previous 164 172 258 266 B-treatment
surgery 173 180 267 274 I-treatment
, 180 181 274 275 O
uveitis 182 189 276 283 B-chronic_disease
, 189 190 283 284 O
congenital 191 201 285 295 B-chronic_disease
, 201 202 295 296 O
developmental 203 216 297 310 B-chronic_disease
or 217 219 311 313 O
structural 220 230 314 324 B-chronic_disease
abnormalities 231 244 325 338 I-chronic_disease
) 244 245 338 339 O

Clinical 0 8 340 348 O
and 9 12 349 352 O
molecular 13 22 353 362 O
diagnosis 23 32 363 372 O
of 33 35 373 375 O
Retinitis 36 45 376 385 B-chronic_disease
Pigmentosa 46 56 386 396 I-chronic_disease
associated 57 67 397 407 O
with 68 72 408 412 O
Usher 73 78 413 418 B-chronic_disease
Syndrome 79 87 419 427 I-chronic_disease
type 88 92 428 432 I-chronic_disease
1B 93 95 433 435 I-chronic_disease

Concomitant 0 11 436 447 O
systemic 12 20 448 456 B-chronic_disease
diseases 21 29 457 465 I-chronic_disease
including 30 39 466 475 O
those 40 45 476 481 O
in 46 48 482 484 O
which 49 54 485 490 O
the 55 58 491 494 O
disease 59 66 495 502 O
itself 67 73 503 509 O
, 73 74 509 510 O
or 75 77 511 513 O
the 78 81 514 517 O
treatment 82 91 518 527 O
for 92 95 528 531 O
the 96 99 532 535 O
disease 100 107 536 543 O
, 107 108 543 544 O
can 109 112 545 548 O
alter 113 118 549 554 O
ocular 119 125 555 561 O
function 126 134 562 570 O
( 135 136 571 572 O
eg 136 138 572 574 O
, 138 139 574 575 O
malignancies 140 152 576 588 B-cancer
, 152 153 588 589 O
diabetes 154 162 590 598 B-chronic_disease
, 162 163 598 599 O
juvenile 164 172 600 608 B-chronic_disease
rheumatoid 173 183 609 619 I-chronic_disease
arthritis 184 193 620 629 I-chronic_disease
or 194 196 630 632 O
sickle 197 203 633 639 B-chronic_disease
cell 204 208 640 644 I-chronic_disease
disease 209 216 645 652 I-chronic_disease
) 216 217 652 653 O

Concurrent 0 10 654 664 O
anti 11 15 665 669 B-treatment
- 15 16 669 670 I-treatment
retroviral 16 26 670 680 I-treatment
therapy 27 34 681 688 I-treatment
that 35 39 689 693 O
would 40 45 694 699 O
inactivate 46 56 700 710 O
the 57 60 711 714 O
investigational 61 76 715 730 O
agent 77 82 731 736 O

Contraindications 0 17 737 754 O
to 18 20 755 757 O
use 21 24 758 761 O
of 25 27 762 764 O
anesthesia 28 38 765 775 B-allergy_name
( 39 40 776 777 O
local 40 45 777 782 O
or 46 48 783 785 O
general 49 56 786 793 O
, 56 57 793 794 O
as 58 60 795 797 O
appropriate 61 72 798 809 O
) 72 73 809 810 O

Current 0 7 811 818 O
or 8 10 819 821 O
anticipated 11 22 822 833 O
treatment 23 32 834 843 O
with 33 37 844 848 O
anticoagulant 38 51 849 862 B-treatment
therapy 52 59 863 870 I-treatment
or 60 62 871 873 O
the 63 66 874 877 O
use 67 70 878 881 O
of 71 73 882 884 O
anticoagulation 74 89 885 900 B-treatment
therapy 90 97 901 908 I-treatment
within 98 104 909 915 O
the 105 108 916 919 O
four 109 113 920 924 B-upper_bound
weeks 114 119 925 930 I-upper_bound
prior 120 125 931 936 I-upper_bound
to 126 128 937 939 O
surgery 129 136 940 947 B-treatment

Current 0 7 948 955 O
treatment 8 17 956 965 O
with 18 22 966 970 O
immunosuppressant 23 40 971 988 B-treatment
therapies 41 50 989 998 O

Enrolment 0 9 999 1008 O
in 10 12 1009 1011 O
any 13 16 1012 1015 O
other 17 22 1016 1021 O
clinical 23 31 1022 1030 O
study 32 37 1031 1036 O
, 37 38 1036 1037 O
for 39 42 1038 1041 O
any 43 46 1042 1045 O
condition 47 56 1046 1055 O
, 56 57 1055 1056 O
including 58 67 1057 1066 O
those 68 73 1067 1072 O
relating 74 82 1073 1081 O
to 83 85 1082 1084 O
Usher 86 91 1085 1090 B-chronic_disease
syndrome 92 100 1091 1099 I-chronic_disease
Type 101 105 1100 1104 I-chronic_disease
1B 106 108 1105 1107 I-chronic_disease
, 108 109 1107 1108 O
throughout 110 120 1109 1119 O
the 121 124 1120 1123 O
duration 125 133 1124 1132 O
of 134 136 1133 1135 O
the 137 140 1136 1139 O
SAR421869 141 150 1140 1149 B-treatment
study 151 156 1150 1155 I-treatment

History 0 7 1156 1163 O
of 8 10 1164 1166 O
any 11 14 1167 1170 O
investigational 15 30 1171 1186 O
agent 31 36 1187 1192 O
within 37 43 1193 1199 O
28 44 46 1200 1202 B-upper_bound
days 47 51 1203 1207 I-upper_bound
prior 52 57 1208 1213 I-upper_bound
to 58 60 1214 1216 O
SAR421869 61 70 1217 1226 B-treatment
administration 71 85 1227 1241 I-treatment

History 0 7 1242 1249 O
of 8 10 1250 1252 O
malignancy 11 21 1253 1263 B-cancer
within 22 28 1264 1270 O
a 29 30 1271 1272 O
five 31 35 1273 1277 B-upper_bound
year 36 40 1278 1282 I-upper_bound
period 41 47 1283 1289 O

Intercurrent 0 12 1290 1302 O
illness 13 20 1303 1310 O
or 21 23 1311 1313 O
infection 24 33 1314 1323 B-chronic_disease
28 34 36 1324 1326 B-upper_bound
days 37 41 1327 1331 I-upper_bound
prior 42 47 1332 1337 I-upper_bound
to 48 50 1338 1340 O
SAR421869 51 60 1341 1350 O
administration 61 75 1351 1365 O

Life 0 4 1366 1370 B-chronic_disease
- 4 5 1370 1371 I-chronic_disease
threatening 5 16 1371 1382 I-chronic_disease
illness 17 24 1383 1390 I-chronic_disease

Males 0 5 1391 1396 B-gender
of 6 8 1397 1399 O
reproductive 9 21 1400 1412 O
potential 22 31 1413 1422 O
must 32 36 1423 1427 O
agree 37 42 1428 1433 B-contraception_consent
with 43 47 1434 1438 I-contraception_consent
their 48 53 1439 1444 I-contraception_consent
partner 54 61 1445 1452 I-contraception_consent
to 62 64 1453 1455 I-contraception_consent
use 65 68 1456 1459 I-contraception_consent
two 69 72 1460 1463 I-contraception_consent
forms 73 78 1464 1469 I-contraception_consent
of 79 81 1470 1472 I-contraception_consent
contraception 82 95 1473 1486 I-contraception_consent
, 95 96 1486 1487 O
including 97 106 1488 1497 O
one 107 110 1498 1501 O
barrier 111 118 1502 1509 O
method 119 125 1510 1516 O
for 126 129 1517 1520 O
at 130 132 1521 1523 O
least 133 138 1524 1529 O
three 139 144 1530 1535 B-lower_bound
months 145 151 1536 1542 I-lower_bound
following 152 161 1543 1552 O
SAR421869 162 171 1553 1562 B-treatment
administration 172 186 1563 1577 I-treatment
if 187 189 1578 1580 O
their 190 195 1581 1586 O
partner 196 203 1587 1594 O
is 204 206 1595 1597 O
of 207 209 1598 1600 O
childbearing 210 222 1601 1613 O
capacity 223 231 1614 1622 O

Men 0 3 1623 1626 B-gender
or 4 6 1627 1629 O
women 7 12 1630 1635 B-gender
who 13 16 1636 1639 O
do 17 19 1640 1642 O
not 20 23 1643 1646 B-contraception_consent
agree 24 29 1647 1652 I-contraception_consent
to 30 32 1653 1655 I-contraception_consent
use 33 36 1656 1659 I-contraception_consent
barrier 37 44 1660 1667 I-contraception_consent
contraception 45 58 1668 1681 I-contraception_consent
as 59 61 1682 1684 O
specified 62 71 1685 1694 O
in 72 74 1695 1697 O
the 75 78 1698 1701 O
inclusion 79 88 1702 1711 O
criteria 89 97 1712 1720 O

Participation 0 13 1721 1734 O
in 14 16 1735 1737 O
a 17 18 1738 1739 O
prior 19 24 1740 1745 B-treatment
gene 25 29 1746 1750 I-treatment
transfer 30 38 1751 1759 I-treatment
therapy 39 46 1760 1767 I-treatment
study 47 52 1768 1773 O

Past 0 4 1774 1778 O
medical 5 12 1779 1786 O
history 13 20 1787 1794 O
of 21 23 1795 1797 O
HIV 24 27 1798 1801 B-chronic_disease
, 27 28 1801 1802 O
or 29 31 1803 1805 O
hepatitis 32 41 1806 1815 B-chronic_disease
A 42 43 1816 1817 I-chronic_disease
, 43 44 1817 1818 I-chronic_disease
B 45 46 1819 1820 I-chronic_disease
or 47 49 1821 1823 I-chronic_disease
C 50 51 1824 1825 I-chronic_disease

Patients 0 8 1826 1834 O
must 9 13 1835 1839 O
agree 14 19 1840 1845 O
to 20 22 1846 1848 O
not 23 26 1849 1852 O
donate 27 33 1853 1859 O
blood 34 39 1860 1865 O
, 39 40 1865 1866 O
organs 41 47 1867 1873 O
, 47 48 1873 1874 O
tissues 49 56 1875 1882 O
or 57 59 1883 1885 O
cells 60 65 1886 1891 O
for 66 69 1892 1895 O
at 70 72 1896 1898 O
least 73 78 1899 1904 O
three 79 84 1905 1910 B-lower_bound
months 85 91 1911 1917 I-lower_bound
following 92 101 1918 1927 O
SAR421869 102 111 1928 1937 O
administration 112 126 1938 1952 O

Pre 0 3 1953 1956 O
- 3 4 1956 1957 O
menopausal 4 14 1957 1967 O
or 15 17 1968 1970 O
non 18 21 1971 1974 O
- 21 22 1974 1975 O
surgically 22 32 1975 1985 O
sterile 33 40 1986 1993 O
women 41 46 1994 1999 B-gender
who 47 50 2000 2003 O
are 51 54 2004 2007 O
unwilling 55 64 2008 2017 B-contraception_consent
to 65 67 2018 2020 I-contraception_consent
use 68 71 2021 2024 I-contraception_consent
an 72 74 2025 2027 I-contraception_consent
effective 75 84 2028 2037 I-contraception_consent
form 85 89 2038 2042 I-contraception_consent
of 90 92 2043 2045 I-contraception_consent
contraception 93 106 2046 2059 I-contraception_consent
such 107 111 2060 2064 O
as 112 114 2065 2067 O
the 115 118 2068 2071 O
contraceptive 119 132 2072 2085 O
pill 133 137 2086 2090 O
or 138 140 2091 2093 O
intrauterine 141 153 2094 2106 O
device 154 160 2107 2113 O

Pregnant 0 8 2114 2122 B-pregnancy

Presence 0 8 2123 2131 O
of 9 11 2132 2134 O
significant 12 23 2135 2146 O
ocular 24 30 2147 2153 B-chronic_disease
abnormalities 31 44 2154 2167 I-chronic_disease
in 45 47 2168 2170 O
the 48 51 2171 2174 O
study 52 57 2175 2180 O
eye 58 61 2181 2184 O
that 62 66 2185 2189 O
in 67 69 2190 2192 O
the 70 73 2193 2196 O
opinion 74 81 2197 2204 O
of 82 84 2205 2207 O
the 85 88 2208 2211 O
investigator 89 101 2212 2224 O
would 102 107 2225 2230 O
preclude 108 116 2231 2239 O
the 117 120 2240 2243 O
planned 121 128 2244 2251 O
surgery 129 136 2252 2259 B-treatment
, 136 137 2259 2260 O
effective 138 147 2261 2270 O
safety 148 154 2271 2277 O
follow 155 161 2278 2284 O
- 161 162 2284 2285 O
up 162 164 2285 2287 O
, 164 165 2287 2288 O
or 166 168 2289 2291 O
interfere 169 178 2292 2301 O
with 179 183 2302 2306 O
the 184 187 2307 2310 O
interpretation 188 202 2311 2325 O
of 203 205 2326 2328 O
study 206 211 2329 2334 O
endpoints 212 221 2335 2344 O
( 222 223 2345 2346 O
eg 223 225 2346 2348 O
, 225 226 2348 2349 O
glaucoma 227 235 2350 2358 B-chronic_disease
, 235 236 2358 2359 O
corneal 237 244 2360 2367 B-chronic_disease
or 245 247 2368 2370 I-chronic_disease
significant 248 259 2371 2382 I-chronic_disease
lens 260 264 2383 2387 I-chronic_disease
opacities 265 274 2388 2397 I-chronic_disease
, 274 275 2397 2398 O
pre 276 279 2399 2402 O
- 279 280 2402 2403 O
existing 280 288 2403 2411 O
uveitis 289 296 2412 2419 B-chronic_disease
, 296 297 2419 2420 O
intraocular 298 309 2421 2432 B-chronic_disease
infection 310 319 2433 2442 I-chronic_disease
, 319 320 2442 2443 O
choroidal 321 330 2444 2453 B-chronic_disease
neovascularization 331 349 2454 2472 I-chronic_disease
) 349 350 2472 2473 O

Treatment 0 9 2474 2483 B-treatment
with 10 14 2484 2488 O
intravitreal 15 27 2489 2501 B-treatment
, 27 28 2501 2502 O
subtenon 29 37 2503 2511 B-treatment
, 37 38 2511 2512 O
or 39 41 2513 2515 O
periocular 42 52 2516 2526 B-treatment
steroid 53 60 2527 2534 I-treatment
within 61 67 2535 2541 O
4 68 69 2542 2543 B-upper_bound
months 70 76 2544 2550 I-upper_bound
of 77 79 2551 2553 O
the 80 83 2554 2557 O
screening 84 93 2558 2567 O
visit 94 99 2568 2573 O

Women 0 5 2574 2579 B-gender
of 6 8 2580 2582 O
childbearing 9 21 2583 2595 O
potential 22 31 2596 2605 O
must 32 36 2606 2610 O
have 37 41 2611 2615 O
a 42 43 2616 2617 O
negative 44 52 2618 2626 O
pregnancy 53 62 2627 2636 B-pregnancy
test 63 67 2637 2641 O
at 68 70 2642 2644 O
screening 71 80 2645 2654 O
and 81 84 2655 2658 O
at 85 87 2659 2661 O
baseline 88 96 2662 2670 O

agree 0 5 2671 2676 B-contraception_consent
to 6 8 2677 2679 I-contraception_consent
use 9 12 2680 2683 I-contraception_consent
an 13 15 2684 2686 I-contraception_consent
effective 16 25 2687 2696 I-contraception_consent
form 26 30 2697 2701 I-contraception_consent
of 31 33 2702 2704 I-contraception_consent
contraception 34 47 2705 2718 I-contraception_consent
such 48 52 2719 2723 O
as 53 55 2724 2726 O
the 56 59 2727 2730 O
contraceptive 60 73 2731 2744 O
pill 74 78 2745 2749 O
or 79 81 2750 2752 O
intra 82 87 2753 2758 O
uterine 88 95 2759 2766 O
device 96 102 2767 2773 O
for 103 106 2774 2777 O
at 107 109 2778 2780 O
least 110 115 2781 2786 O
three 116 121 2787 2792 B-lower_bound
months 122 128 2793 2799 I-lower_bound
following 129 138 2800 2809 O
SAR421869 139 148 2810 2819 B-treatment
administration 149 163 2820 2834 O

aphakia 0 7 2835 2842 B-treatment
or 8 10 2843 2845 O
prior 11 16 2846 2851 B-treatment
vitrectomy 17 27 2852 2862 I-treatment
, 27 28 2862 2863 O
in 29 31 2864 2866 O
the 32 35 2867 2870 O
study 36 41 2871 2876 O
eye 42 45 2877 2880 O
within 46 52 2881 2887 O
6 53 54 2888 2889 B-upper_bound
months 55 61 2890 2896 I-upper_bound
of 62 64 2897 2899 O
screening 65 74 2900 2909 O

ataract 0 7 2910 2917 B-treatment
surgery 8 15 2918 2925 I-treatment
with 16 20 2926 2930 O
intraocular 21 32 2931 2942 B-treatment
lens 33 37 2943 2947 I-treatment
implantation 38 50 2948 2960 I-treatment

breastfeeding 0 13 2961 2974 O
women 14 19 2975 2980 B-gender

caused 0 6 2981 2987 O
by 7 9 2988 2990 O
at 10 12 2991 2993 O
least 13 18 2994 2999 O
one 19 22 3000 3003 B-lower_bound
pathogenic 23 33 3004 3014 B-chronic_disease
MYO7A 34 39 3015 3020 I-chronic_disease
mutation 40 48 3021 3029 I-chronic_disease
on 49 51 3030 3032 O
both 52 56 3033 3037 O
alleles 57 64 3038 3045 O

diagnostic 0 10 3046 3056 B-treatment
agents 11 17 3057 3063 I-treatment
used 18 22 3064 3068 O
during 23 29 3069 3075 O
the 30 33 3076 3079 O
study 34 39 3080 3085 O
( 40 41 3086 3087 O
eg 41 43 3087 3089 O
, 43 44 3089 3090 O
fluorescein 45 56 3091 3102 B-treatment
, 56 57 3102 3103 O
dilation 58 66 3104 3112 B-treatment
drops 67 72 3113 3118 I-treatment
) 72 73 3118 3119 O
, 73 74 3119 3120 O
or 75 77 3121 3123 O
medications 78 89 3124 3135 O
planned 90 97 3136 3143 O
for 98 101 3144 3147 O
use 102 105 3148 3151 O
during 106 112 3152 3158 O
the 113 116 3159 3162 O
peri 117 121 3163 3167 O
- 121 122 3167 3168 O
operative 122 131 3168 3177 O
period 132 138 3178 3184 O
, 138 139 3184 3185 O
particularly 140 152 3186 3198 O
topical 153 160 3199 3206 O
, 160 161 3206 3207 O
injected 162 170 3208 3216 O
or 171 173 3217 3219 O
systemic 174 182 3220 3228 B-treatment
corticosteroids 183 198 3229 3244 I-treatment

have 0 4 3245 3249 O
had 5 8 3250 3253 O
a 9 10 3254 3255 O
positive 11 19 3256 3264 B-cancer
cancer 20 26 3265 3271 I-cancer
screening 27 36 3272 3281 O
test 37 41 3282 3286 O
within 42 48 3287 3293 O
a 49 50 3294 3295 O
one 51 54 3296 3299 B-upper_bound
year 55 59 3300 3304 I-upper_bound
period 60 66 3305 3311 O
of 67 69 3312 3314 O
the 70 73 3315 3318 O
screening 74 83 3319 3328 O
visit 84 89 3329 3334 O

with 0 4 3335 3339 O
the 5 8 3340 3343 O
last 9 13 3344 3348 O
menstrual 14 23 3349 3358 O
period 24 30 3359 3365 O
being 31 36 3366 3371 O
over 37 41 3372 3376 O
two 42 45 3377 3380 B-upper_bound
years 46 51 3381 3386 I-upper_bound
prior 52 57 3387 3392 I-upper_bound
to 58 60 3393 3395 O
enrolment 61 70 3396 3405 O

